In recent weeks, Japan has been grappling with a surge in COVID-19 cases attributed to the BQ.1.1 variant, colloquially known as 'Hellhound.' This subvariant, a descendant of Omicron's BA.5 lineage, has been characterized by its high transmissibility and elevated mortality rates, leading to significant public health concerns. The rapid spread of 'Hellhound' has overwhelmed healthcare facilities, prompting urgent calls for enhanced preventive measures and accelerated vaccination efforts. The emergence of BQ.1.1 is not an isolated incident. Globally, the Omicron variant and its subvariants, including BQ.1.1, have been identified in numerous countries, with varying impacts on public health. In Japan, the National Institute of Infectious Diseases has been closely monitoring these developments, noting the increased prevalence of BQ.1.1 since October 2022. Despite its rapid spread, there have been no significant changes in viral characteristics, such as severity and infectivity, apart from an increase in the number of infected cases and the possibility of immune escape between subvariants. The Institute continues to classify the subvariants as before, emphasizing the need for ongoing monitoring and information collection through genomic analysis and quarantine measures. The rapid rise of 'Hellhound' has raised alarms about the potential for immune evasion. Studies have shown that Omicron subvariants, including BQ.1.1, exhibit mutations in the spike protein that may allow the virus to evade neutralizing antibodies generated through vaccination or previous infection. This has led to concerns about the effectiveness of existing vaccines against this subvariant. In response, health authorities have been advocating for booster vaccinations and other preventive measures to mitigate the impact of 'Hellhound' and similar variants. The situation in Japan serves as a stark reminder of the ever-evolving nature of the COVID-19 virus. The emergence of new variants like BQ.1.1 underscores the importance of continuous surveillance, rapid response strategies, and public compliance with health guidelines. As the global community continues to battle the pandemic, the experience of Japan with 'Hellhound' may offer valuable lessons in managing future outbreaks. In conclusion, Japan's struggle with the 'Hellhound' variant highlights the persistent challenges posed by COVID-19. The high transmissibility and potential for immune evasion of BQ.1.1 necessitate a coordinated response, including enhanced vaccination campaigns, public health interventions, and international collaboration to control the spread of this and future variants.